View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 8, 2021

LSK Global selects Veeva’s clinical applications to simplify trial processes

Korean contract research organisation LSK Global Pharma Services has adopted three Veeva vault clinical applications to streamline the global trial processes.

Korean contract research organisation LSK Global Pharma Services has adopted three Veeva vault clinical applications to streamline the global trial processes.

LSK Global will use Veeva Vault eTMF, Veeva Vault CTMS, and Veeva SiteVault Free applications to streamline the trial process and remotely collaborate with study sponsors to review and verify the documents.

LSK Global Pharma Services president Young-Jack Lee said: “As a leading CRO, our aim is to run faster, more efficient trials.

“Veeva Vault Clinical applications enable us to operate remote trials, provides full visibility into end-to-end trial activities, and improves our collaboration with sponsors.”

Vault eTMF and Vault CTMS are part of Veeva vault clinical suite, which is claimed to be the industry’s first cloud platform that unifies clinical data management as well as the operations.

Vault eTMF (electronic trial master file) is said to be the only software that manages documents in real-time.

It ensures a constant state of inspection readiness by managing all TMF documents and processes in the same eTMF system.

The Veeva Vault CTMS improves operational efficiency, streamlines collaboration, and enables quick, high-quality trial execution.

Meanwhile, SiteVault Free, a free eRegulatory solution for clinical research sites, replaces the paper-based process and simplifies research by providing a modern Cloud application to manage investigator site files.

All the three applications together will allow LSK Global to fast-track the trial execution process and deliver real-time visibility within a short span of time.

Established in 2000, the company provides therapeutic area-specific services across oncology, cardiovascular disease and endocrinology.

As of December last year, it has conducted 1,277 clinical studies, including 144 global clinical studies and 110 IND studies.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU